(RMH) - Stem Cell & Immunotherapy services

The procurement process for Stem Cell & Immunotherapy services has been conducted by The Royal Marsden NHS Foundation Trust, a regional authority focused on health services. This contract is classified under services provided by blood banks (CPV 85146000) and was awarded through a direct award without prior publication, falling outside the directive scope. The procurement process was concluded with an award made on 1st April 2025, valued at £25,000.

The services are to be delivered within the UKI33 region, specifically in London. The contract has been signed with NHS Blood and Transplant (NHSBT) as the supplier, and the status of the lot involved is currently marked as cancelled, indicating potential complications post-award. This tender represents a significant opportunity for businesses specialising in health services, particularly those offering blood banking or similar capabilities, to engage with The Royal Marsden NHS Foundation Trust.

Despite this specific process being closed to competition, understanding such direct award procedures and building rapport with regional authorities like the Royal Marsden can be invaluable for future opportunities. Businesses that are familiar with health sector compliance and can provide specialised services might be well-positioned to secure similar contracts through strategic partnerships or direct awards.